Nature Communications (Apr 2024)

TAD boundary deletion causes PITX2-related cardiac electrical and structural defects

  • Manon Baudic,
  • Hiroshige Murata,
  • Fernanda M. Bosada,
  • Uirá Souto Melo,
  • Takanori Aizawa,
  • Pierre Lindenbaum,
  • Lieve E. van der Maarel,
  • Amaury Guedon,
  • Estelle Baron,
  • Enora Fremy,
  • Adrien Foucal,
  • Taisuke Ishikawa,
  • Hiroya Ushinohama,
  • Sean J. Jurgens,
  • Seung Hoan Choi,
  • Florence Kyndt,
  • Solena Le Scouarnec,
  • Vincent Wakker,
  • Aurélie Thollet,
  • Annabelle Rajalu,
  • Tadashi Takaki,
  • Seiko Ohno,
  • Wataru Shimizu,
  • Minoru Horie,
  • Takeshi Kimura,
  • Patrick T. Ellinor,
  • Florence Petit,
  • Yves Dulac,
  • Paul Bru,
  • Anne Boland,
  • Jean-François Deleuze,
  • Richard Redon,
  • Hervé Le Marec,
  • Thierry Le Tourneau,
  • Jean-Baptiste Gourraud,
  • Yoshinori Yoshida,
  • Naomasa Makita,
  • Claude Vieyres,
  • Takeru Makiyama,
  • Stephan Mundlos,
  • Vincent M. Christoffels,
  • Vincent Probst,
  • Jean-Jacques Schott,
  • Julien Barc

DOI
https://doi.org/10.1038/s41467-024-47739-x
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 15

Abstract

Read online

Abstract While 3D chromatin organization in topologically associating domains (TADs) and loops mediating regulatory element-promoter interactions is crucial for tissue-specific gene regulation, the extent of their involvement in human Mendelian disease is largely unknown. Here, we identify 7 families presenting a new cardiac entity associated with a heterozygous deletion of 2 CTCF binding sites on 4q25, inducing TAD fusion and chromatin conformation remodeling. The CTCF binding sites are located in a gene desert at 1 Mb from the Paired-like homeodomain transcription factor 2 gene (PITX2). By introducing the ortholog of the human deletion in the mouse genome, we recapitulate the patient phenotype and characterize an opposite dysregulation of PITX2 expression in the sinoatrial node (ectopic activation) and ventricle (reduction), respectively. Chromatin conformation assay performed in human induced pluripotent stem cell-derived cardiomyocytes harboring the minimal deletion identified in family#1 reveals a conformation remodeling and fusion of TADs. We conclude that TAD remodeling mediated by deletion of CTCF binding sites causes a new autosomal dominant Mendelian cardiac disorder.